ArticleFrontiers in immunology2026
Integrative single-cell and bulk transcriptomic analysis identify R-loop-associated gene signatures driving immune-inflammatory networks in acute pancreatitis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: R-loop dysregulation has been implicated in chronic inflammation via DNA damage and cytoplasmic ssDNA release, yet its role in acute pancreatitis (AP) remains to be systematically investigated. This study aimed to identify R-loop-related biomarkers in AP and elucidate their potential roles in immune-inflammatory networks through integrative bioinformatics analysis and Methods: Single-cell and bulk transcriptomic datasets from the GEO database were integrated to calculate R-loop-related gene (RLRG) scores across cell types using multiple scoring algorithms. High-dimensional weighted gene co-expression network analysis (hdWGCNA), differential expression analysis, and machine learning algorithms (LASSO, SVM-RFE, and Boruta) were applied to screen candidate gene signatures. Immune infiltration and functional enrichment analyses were performed to investigate the regulatory mechanisms of identified gene signatures. A caerulein-induced AR42J cell model was established for experimental validation, and siRNA-mediated knockdown was conducted to assess functional roles. Results: Fibroblasts emerged as the primary cell type with elevated RLRG scores and significant differences between AP and control groups. Pseudotime analysis revealed that AP promotes fibroblast progression toward terminal differentiation, with high-RLRG-score cells exhibiting greater stemness and intercellular communication activity. Three candidate gene signatures-Anp32b, Myl12a, and Nras-were identified and showed markedly increased expression in the AP cohort. These genes exhibited significant correlations with immune cell populations and were enriched in immune-inflammatory, apoptotic, cytoskeletal, and proteasome pathways. The upregulation of Anp32b and Myl12a was confirmed in the caerulein-induced AR42J cell model. siRNA-mediated Myl12a knockdown attenuated trypsin activation and reduced inflammatory cytokine release, while immunofluorescence staining with the S9.6 antibody demonstrated that Myl12a knockdown significantly reduced nuclear R-loop accumulation. Conclusions: These findings highlight R-loop-associated gene signatures and functionally validated Myl12a as plausible candidates for dissecting AP pathogenesis. This work provides mechanistic clues for AP-related immune-inflammatory, which need further researches to verify.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.